WHO ICTRP trial

To Evaluate Safety and Performance of the BioMimeTM -Sirolimus Eluting Coronary…

CTRI/2016/11/007475 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2016/11/007475
Public title To Evaluate Safety and Performance of the BioMimeTM -Sirolimus Eluting Coronary Stent system for the treatment of patients with coronary artery lesions
Scientific title THE FIRST-IN-MAN SAFETY AND PERFORMANCE EVALUATION OF THE BIOMIMETM -SIROLIMUS-ELUTING STENT SYSTEM FOR THE TREATMENT OF PATIENTS WITH SINGLE, DE NOVO, NON-COMPLEX CORONARY LESIONS- THE BIOMIMETM PILOT FIM TRIAL - meriT-1
Primary sponsor Meril Life Sciences India Pvt Ltd
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type PMS
Phase Phase 4
Countries India
Conditions Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Interventions Intervention1: BioMimeâ?¢ - Sirolimus Eluting stents: Treatment Of Patients with single, De-Novo, Coronary Artery Lesions. This device has the particularity to be covered by Sirolimus, in order to prevent in an effective way the…
Registration date Nov 23, 2016
Target size 30
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations